• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 脱落动力学和免疫抑制患者中的传播。

SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.

机构信息

Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Virulence. 2022 Dec;13(1):1242-1251. doi: 10.1080/21505594.2022.2101198.

DOI:10.1080/21505594.2022.2101198
PMID:35891618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9336477/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have been emerging. However, knowledge of temporal and spatial dynamics of SARS-CoV-2 is limited. This study characterized SARS-CoV-2 evolution in immunosuppressed patients with long-term SARS-CoV-2 shedding for 73-250 days, without specific treatment. We conducted whole-genome sequencing of 27 serial samples, including 26 serial samples collected from various anatomic sites of two patients and the first positive sample from patient 2's mother. We analysed the intrahost temporal dynamics and genomic diversity of the viral population within different sample types. Intrahost variants emerging during infection showed diversity between individual hosts. Remarkably, N501Y, P681R, and E484K, key substitutions within spike protein, emerged during infection and became the dominant population. P681R, which had not yet been detected in the publicly available genome in Korea, appeared within patient 1 during infection. Mutually exclusive substitutions at residues R346 (R346S and R346I) and E484 (E484K and E484A) of spike protein and continuous turnover of these substitutions occurred. Unique genetic changes were observed in urine samples. A household transmission from patient 2 to his mother, at least 38 days after the diagnosis, was characterized. Viruses may differently mutate and adjust to the host selective pressure, which could enable the virus to replicate efficiently for fitness in each host. Intrahost variants could be candidate variants likely to spread to the population eventually. Our findings may provide new insights into the dynamics of SARS-CoV-2 in response to interactions between the virus and host.

摘要

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的关切变种不断出现。然而,人们对 SARS-CoV-2 的时间和空间动态知之甚少。本研究对 27 个连续样本进行了全基因组测序,包括两名患者的 26 个连续样本和患者 2 母亲的第一个阳性样本,这些患者在没有特定治疗的情况下,长期(73-250 天)排出 SARS-CoV-2。我们分析了不同样本类型中病毒种群的宿主内时间动态和基因组多样性。感染过程中出现的宿主内变体在个体宿主之间表现出多样性。值得注意的是,棘突蛋白内的关键突变 N501Y、P681R 和 E484K 在感染过程中出现并成为主要种群。尚未在韩国公开基因组中检测到的 P681R 出现在患者 1 的感染过程中。棘突蛋白中残基 R346(R346S 和 R346I)和 E484(E484K 和 E484A)的互斥替代以及这些替代的连续更替发生。在尿液样本中观察到独特的遗传变化。从患者 2 向其母亲的家庭传播至少发生在诊断后 38 天。病毒可能会以不同的方式突变并适应宿主的选择压力,这使病毒能够在每个宿主中高效复制以适应生存。宿主内变体可能是最终传播到人群中的候选变体。我们的发现可能为研究 SARS-CoV-2 对病毒与宿主相互作用的反应提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/b5f5eb552278/KVIR_A_2101198_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/0357dc88c3a0/KVIR_A_2101198_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/116b4881b031/KVIR_A_2101198_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/f7010b3b9f01/KVIR_A_2101198_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/17c9fb77efea/KVIR_A_2101198_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/b5f5eb552278/KVIR_A_2101198_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/0357dc88c3a0/KVIR_A_2101198_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/116b4881b031/KVIR_A_2101198_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/f7010b3b9f01/KVIR_A_2101198_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/17c9fb77efea/KVIR_A_2101198_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/9336477/b5f5eb552278/KVIR_A_2101198_F0005_B.jpg

相似文献

1
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.SARS-CoV-2 脱落动力学和免疫抑制患者中的传播。
Virulence. 2022 Dec;13(1):1242-1251. doi: 10.1080/21505594.2022.2101198.
2
Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.描述 SARS-CoV-2 刺突蛋白 E484 表位中暂时固定突变引起的固有和有效适应性变化,并鉴定变异株奥密克戎中 E484A 进化的上位条件。
Virol J. 2023 Nov 8;20(1):257. doi: 10.1186/s12985-023-02154-4.
3
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
4
Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.长达一年的 COVID-19 感染揭示了 B 细胞耗竭患者体内 SARS-CoV-2 的宿主内进化。
J Infect Dis. 2022 Apr 1;225(7):1118-1123. doi: 10.1093/infdis/jiab622.
5
SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.SARS-CoV-2 准种为流行变异株提供了有利的突变库。
Microbiol Spectr. 2021 Sep 3;9(1):e0026121. doi: 10.1128/Spectrum.00261-21. Epub 2021 Aug 4.
6
Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.SARS-CoV-2 前融合刺突蛋白变体的构象转变、谱系比较及从头至尾三聚体状态分析,包括英国 B.1.1.7 变体。
Microbiol Spectr. 2021 Sep 3;9(1):e0003021. doi: 10.1128/Spectrum.00030-21. Epub 2021 Aug 4.
7
Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.免疫功能低下宿主体内 SARS-CoV-2 刺突突变的长期感染中出现。
Microbiol Spectr. 2022 Jun 29;10(3):e0079122. doi: 10.1128/spectrum.00791-22. Epub 2022 May 11.
8
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.鉴定具有增强致细胞病变和融合作用的 SARS-CoV-2 高频宿主内刺突变异株。
mBio. 2021 Jun 29;12(3):e0078821. doi: 10.1128/mBio.00788-21.
9
A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.一种基于多重 PCR-质谱微测序技术的 SARS-CoV-2 变体检测新策略。
Microbiol Spectr. 2021 Dec 22;9(3):e0126721. doi: 10.1128/Spectrum.01267-21. Epub 2021 Nov 17.
10
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.COVID-19 住院患者中 SARS-CoV-2 感染的持续性及病毒的体内和种间进化。
J Med Virol. 2024 Jun;96(6):e29708. doi: 10.1002/jmv.29708.

引用本文的文献

1
The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages.既往免疫对奥密克戎谱系宿主内免疫逃逸突变出现的影响。
J Gen Virol. 2025 May;106(5). doi: 10.1099/jgv.0.002108.
2
Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022.2020年1月至2022年2月期间,欧洲新冠肺炎队列中不断演变的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的准种流行情况及临床影响
Euro Surveill. 2025 Mar;30(10). doi: 10.2807/1560-7917.ES.2025.30.10.2400038.
3
Impact of Prolonged SARS-CoV-2 Viral Shedding on COVID-19 Disease Outcome and Viral Dynamics.

本文引用的文献

1
Evolutionary trajectory of SARS-CoV-2 and emerging variants.SARS-CoV-2 的进化轨迹和新兴变种。
Virol J. 2021 Aug 13;18(1):166. doi: 10.1186/s12985-021-01633-w.
2
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.印度马哈拉施特拉邦第二波新冠疫情中出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变,L452R、T478K、E484Q和P681R
Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.
3
SARS-CoV-2 Variants and Vaccines.SARS-CoV-2 变异株与疫苗。
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)长期病毒脱落对冠状病毒病2019(COVID-19)疾病结局和病毒动力学的影响
Indian J Microbiol. 2024 Dec;64(4):1416-1424. doi: 10.1007/s12088-024-01238-1. Epub 2024 Mar 27.
4
Multi-Organ Spread and Intra-Host Diversity of SARS-CoV-2 Support Viral Persistence, Adaptation, and a Mechanism That Increases Evolvability.新型冠状病毒的多器官传播及宿主内多样性支持病毒持续存在、适应以及一种增加进化能力的机制。
J Med Virol. 2024 Dec;96(12):e70107. doi: 10.1002/jmv.70107.
5
Advancing respiratory virus diagnostics: integrating the nasal IFN-I score for improved viral detection.推进呼吸道病毒诊断:整合鼻腔I型干扰素评分以改善病毒检测
EBioMedicine. 2024 Dec;110:105450. doi: 10.1016/j.ebiom.2024.105450. Epub 2024 Nov 21.
6
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.描述抗体介导的选择压力如何驱动 SARS-CoV-2 在持续性感染期间在宿主内进化。
PLoS Pathog. 2024 Oct 15;20(10):e1012624. doi: 10.1371/journal.ppat.1012624. eCollection 2024 Oct.
7
Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients.病例报告显示,免疫功能低下患者的 SARS-CoV-2 持续感染概述了体内病毒进化。
Virol J. 2024 Sep 3;21(1):210. doi: 10.1186/s12985-024-02483-y.
8
SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient.免疫功能低下的成年患者体内的 SARS-CoV-2 脱落、感染性和进化情况。
Rev Inst Med Trop Sao Paulo. 2024 May 13;66:e28. doi: 10.1590/S1678-9946202466028. eCollection 2024.
9
Whole-Genome Sequencing and Mutation Analyses of SARS-CoV-2 Isolates from Indonesia.来自印度尼西亚的新型冠状病毒肺炎病毒分离株的全基因组测序与突变分析
Pathogens. 2024 Mar 25;13(4):279. doi: 10.3390/pathogens13040279.
10
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.宿主内进化分析支持免疫抑制患者的 SARS-CoV-2 病毒储存库假说。
Viruses. 2024 Feb 23;16(3):342. doi: 10.3390/v16030342.
N Engl J Med. 2021 Jul 8;385(2):179-186. doi: 10.1056/NEJMsr2105280. Epub 2021 Jun 23.
4
Novel SARS-CoV-2 variants: the pandemics within the pandemic.新型 SARS-CoV-2 变体:大流行中的大流行。
Clin Microbiol Infect. 2021 Aug;27(8):1109-1117. doi: 10.1016/j.cmi.2021.05.022. Epub 2021 May 17.
5
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.SARS-CoV-2 变异株 P.1 对抗体中和的抵抗力增强。
Cell Host Microbe. 2021 May 12;29(5):747-751.e4. doi: 10.1016/j.chom.2021.04.007. Epub 2021 Apr 18.
6
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白E484K突变降低抗体中和作用。
Lancet Microbe. 2021 Jul;2(7):e283-e284. doi: 10.1016/S2666-5247(21)00068-9. Epub 2021 Apr 7.
7
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.SARS-CoV-2 刺突蛋白的中和抗体逃逸:基于抗体的新冠病毒治疗和疫苗的风险评估。
Rev Med Virol. 2021 Nov;31(6):e2231. doi: 10.1002/rmv.2231. Epub 2021 Mar 16.
8
SARS-CoV-2 within-host diversity and transmission.SARS-CoV-2 宿主内多样性和传播。
Science. 2021 Apr 16;372(6539). doi: 10.1126/science.abg0821. Epub 2021 Mar 9.
9
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
10
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)人际传播期间的种群瓶颈和宿主内进化
Front Med (Lausanne). 2021 Feb 15;8:585358. doi: 10.3389/fmed.2021.585358. eCollection 2021.